Related Experiment Video
Updated: Jun 3, 2025

06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.3K
FDA Approves Inavolisib Combo for PIK3CA-Mutated, HR+ Breast Cancer
Jinwei Zhang1,2
1Institute of Biomedical and Clinical Sciences, Medical School, Faculty of Health and Life Sciences, University of Exeter, Hatherly Laboratories, Streatham Campus, Exeter, EX4 4PS, UK.
Current Medicinal Chemistry
|January 10, 2025
Abstract
No abstract available in PubMed .

